Torkore is very pleased to announce that Dr. Michael Olah will be joining the Board of Torkore with immediate effect as a Non-executive Director and as a Consultant.

Michael a Medical Doctor and graduate of the University of Toronto and Charles University is fluent in both English and Slovak. Michael is highly engaged and active in his local community and runs a solo medical practice which is part of the St. Joseph’s Family Health Group.

After completing his medical degree, Michael completed further training at the University of Western Ontario and the Rothbart Pain Clinic. In addition, Michael was a member of the Family Medicine Longitudinal Experience run through the University of Toronto, an organization that introduced students to the field of Family Medicine, where he was both a member of the committee setting policy for the University as well as Professional Development Liaison educating physicians on training medical students. He is currently a preceptor for the University of Toronto, and his teaching has included training individuals at all levels including residents.

Michael’s ongoing professional development includes education in Canada, United States, Europe and South America. Michaels experience studying in both North America and Europe has enabled him to have a well-rounded and unique perspective on medicine and patient care.

A past promoter of special events in the pharmaceutical field in both Canada and Europe, Michael has continued to maintain his relationship with the pharmaceutical industry. This includes training pharmaceutical representatives and sitting on committees as an expert in the field of medicine.

Tim Scurry Said “Michael has graciously consented to join the Torkore board and in doing so brings a unique perspective to our overall strategy and deep knowledge of healthcare. He has extensive connections in the community and continues to remain very active in promoting new innovations in patient care. I am delighted to welcome him to the board”.

Michael Olah said “I am excited to be able to contribute as both a board member and as a consultant and believe that there are many exciting innovations, that are now in reach, that will significantly improve patient and treatment outcomes at the same time as reducing the cost to deliver those services”.